Blinatumomab for infant acute lymphoblastic leukemia

Blood. 2020 Apr 23;135(17):1501-1504. doi: 10.1182/blood.2019004008.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Prognosis
  • Retrospective Studies
  • Survival Rate

Substances

  • Antibodies, Bispecific
  • Antineoplastic Agents
  • blinatumomab